FDA: Risk Evaluation and Mitigation Strategies (REMS) Paper on Program Evaluations and Outcomes Read more
Senate Finance Committee Reacts to Reports of Opioid Abuse and Conflict of Interests: Letters to Manufactures and Organizations Read more